Cetus Protocol vs Injective — how do they compare? Cetus Protocol trades at Rp319 (market cap Rp306,42M, Rp37,13M 24h volume), while Injective trades at Rp84,882 (market cap Rp8,46T, Rp1,38T 24h volume). The key difference: Injective is far larger — about 27609.2× Cetus Protocol's market cap, and Cetus Protocol's supply is capped (956,5M / 1B CETUS (96%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Cetus Protocol for 30 Days and Injective for 36 Days on average.
| CETUS | INJ | |
|---|---|---|
Market Cap | Rp306,42M | Rp8,46T |
Volume (24h) | Rp37,13M | Rp1,38T |
Circulating Supply | 956,5M / 1B CETUS (96%) | 100M INJ |
Typical Hold Time | 30 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
Cetus Protocol is currently trading at Rp327.32 with a market cap of Rp309.4M, showing bearish technical signals overall. The asset faces selling pressure with moving averages indicating bearish momentum while oscillators remain neutral. Key support levels are at Rp311-320, with resistance at Rp330-340. The token has 96% circulating supply with typical 30-day holding patterns.
Overall outlook remains cautious with technical indicators favoring sellers. Key opportunity lies in potential bounce from support levels, while major risks include continued bearish momentum and limited liquidity. Investors should monitor volume patterns and ecosystem developments for directional cues.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Cetus Protocol, a decentralized exchange and liquidity protocol, operates on the Sui and Aptos blockchains. It leverages the Concentrated Liquidity Market Makers (CLMM) paradigm, integrating elements from Uniswap V3 and Trader Joe to offer advanced trading and liquidity options. Cetus aims to build a robust and flexible liquidity network, enhancing trading experiences and liquidity efficiency for DeFi users.
Read more on CETUS →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →